Back to search

Article

Association between with Serum neurofilament light and neurochemistry deficits in patients with spinocerebellar ataxia type 3

2022-10-14

Abstract excerpt

Extensive evidence supports the claim that serum neurofilament light chain (sNfL) can be used as a biomarker for monitoring disease severity in patients with spinocerebellar ataxia type 3 (SCA3). However, little is known about the associations between sNfL levels and neurochemical alterations in SCA3 patients. Serum samples were collected from ATXN3 mutation carriers ( n  = 20) and normal controls ( n  = 14). sNfL...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e4d87a7a-6e71-5352-92e7-de3d96c74004
DOI
10.21203/rs.3.rs-2132253/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Association between with Serum neurofilament light and neurochemistry deficits in patients with spinocerebellar ataxia type 3DOI 10.21203/rs.3.rs-2132253/v1
Select a neighboring publication to make it the new centre.